March 30, 2017 -Paving the way towards personalized medicine
In the article ‘Diagnostic medical technology veering into Star Trek galaxies’, the author discusses some recent advancements in diagnostic imaging, and highlights how these are paving the way towards personalized medicine.
There’s definitely a need for more diagnostic tools as well as documentation tools
… Read MoreMarch 6, 2017 -Reliability in microbiology wound sampling
In the article ‘Improved detection of clinically relevant wound bacteria using autofluorescence image-guided sampling in diabetic foot ulcers’ recently published (March 2017) in International Wound Journal, Ottolino-Perry et al. present data from a clinical trial highlighting how the conventional Levine method of sampling may need to be reconsidered
… Read MoreFebruary 24, 2017 -Challenges and future outlook in the management of the diabetic foot
The MolecuLight i:X was recently featured in a timely invited review article discussing the current challenges and future outlook in the management of diabetic foot. As many of us know, diabetic foot ulcers, are a serious health problem in
… Read MoreJanuary 16, 2017 -Case of Nevada women another sign that antibiotic resistance must be taken seriously
Public health officials from Nevada are reporting on a case of a woman who died in Reno in September from an incurable infection caused by Klebsiella pneumoniae bacteria. Testing showed the superbug that had spread throughout her
… Read MoreDecember 23, 2016 -
Keeping up with their tradition, MolecuLight Inc. participated as a secret Santa in the Adopt-a-Senior 2016 program through LOFT Community Services. This charity provides attention to seniors who deal with loneliness and uncertainty at this special time of the year.
MolecuLight Inc. would like to wish everyone a happy and healthy
… Read MoreNovember 3, 2016 -22nd Annual CAWC Conference in Niagara Falls
The MolecuLight i:X Imaging Device was highly represented in the Oral Poster Presentations Infection Session at the 22nd Annual CAWC Conference in Niagara Falls.
Over 600 registrants and 230 Industry Personnel attended the CAWC Conference, November 3-6 in Niagara Falls.
As a corporate sponsor,
… Read MoreSeptember 16, 2016 -MolecuLight i:X wound care device instantly visualizes potentially harmful bacterial loads
TORONTO – September 16, 2016 – MolecuLight Inc. has received CE Mark approval authorizing commercial sales in the European Union of its MolecuLight i:X Imaging Device, that is revolutionizing wound care.
The MolecuLight i:X will be making its European debut at
… Read MoreAugust 23, 2016 -Reviewing medical imaging in wound care
There’s no doubt that while medical imaging is standard and routine in most medical fields (e.g. cardiology, oncology, gynecology, etc.), it is far behind in the field of wound care. The recent editorial in Advances in Wound Care highlights the key points of four
… Read MoreJune 23, 2016 -MolecuLight i:X Exhibited at 2016 WOCN Society & CAET Joint Conference
The event was organized by The Wound, Ostomy and Continence Nurses SocietyTM (WOCN®) – recognized worldwide for the promotion of safe and effective wound, ostomy and continence (WOC) care – and The Canadian Association for Enterostomal Therapy (CAET) –
… Read More
MolecuLight is SOC ll®
Type l Accredited:
MolecuLight awarded
Premier’s Technology
Breakthrough Designation
MolecuLight i:X
is designated as a:
MolecuLight included
in ISWCAP Consensus
Guidelines:
MolecuLight is a proud
corporate member of:
©2025
The MolecuLight® i:X and MolecuLightDX™ Imaging Devices are approved by Health Canada for sale in Canada and has CE marking for sale in the European Union.
The MolecuLight™ i:X and DX Imaging Devices have received FDA clearance.